Código QR (código de barras bidimensional)

Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review

Janus kinase (JAK) inhibitors have heralded a paradigm shift in the management of immune-mediated diseases. While their efficacy is well-established, the safety concerns associated with these agents, particularly regarding thromboembolic events (TE), remain a focus of extensive research and clinical...

Fuld beskrivelse

Na minha lista:
Principais autores: Krasimir Kraev, Mariela Gencheva Geneva-Popova, Bozhidar Krasimirov Hristov, Petar Angelov Uchikov, Stanislava Dimitrova Belova-Popova, Maria Ilieva Kraeva, Yordanka Mincheva Basheva-Kraeva, Nina Staneva Stoyanova, Vesela Todorova Mitkova-Hristova, Maria Stoyanova Koleva-Ivanova, Daniela Ivova Taneva, Atanas Slavchev Ivanov
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2023-11-01
Serier:Life
Fag:
JAK inhibitors
immune-mediated diseases
safety profile
adverse events
Online adgang:https://www.mdpi.com/2075-1729/13/12/2244
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker